PRTN3 and Arthralgia: Meanwhile, a prediction rule for RA development in seropositive (ACPA and/or IgM RF-positive) arthralgia patients categorized patients into 3 risk groups based on risk variables including FDR status, alcohol non-use, duration of symptoms < 12 months, presence of intermittent symptoms, and antibody status.